Ghiath M. Sukhtian is Director & 10% Owner at Outlook Therapeutics, Inc. (OTLK). They have made 3 open-market trades across 1 company since 2017, most recently 2026-08-12.
CIK 0001717441
3 open-market purchases totalling $27.5M since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONS | 44,327,383 | $28.6M |
| OTLK | 2,525,252 | $1.2M |
| Total | $29.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.